Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to $141843.0.

  • Iradimed's Other Working Capital Changes rose 30383.84% to $141843.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 15882.19%. This contributed to the annual value of $320233.0 for FY2024, which is 4798.34% down from last year.
  • According to the latest figures from Q3 2025, Iradimed's Other Working Capital Changes is $141843.0, which was up 30383.84% from $789003.0 recorded in Q2 2025.
  • Iradimed's Other Working Capital Changes' 5-year high stood at $1.0 million during Q4 2023, with a 5-year trough of -$904098.0 in Q3 2022.
  • Over the past 5 years, Iradimed's median Other Working Capital Changes value was $141843.0 (recorded in 2025), while the average stood at $209607.6.
  • As far as peak fluctuations go, Iradimed's Other Working Capital Changes crashed by 250774.18% in 2021, and later surged by 73859.77% in 2025.
  • Iradimed's Other Working Capital Changes (Quarter) stood at $374639.0 in 2021, then skyrocketed by 162.49% to $983398.0 in 2022, then grew by 5.14% to $1.0 million in 2023, then tumbled by 45.37% to $564839.0 in 2024, then plummeted by 74.89% to $141843.0 in 2025.
  • Its last three reported values are $141843.0 in Q3 2025, $789003.0 for Q2 2025, and $547207.0 during Q1 2025.